Kambiz Yazdi
Stock Analyst at BTIG
(4.09)
# 1,657
Out of 4,974 analysts
79
Total ratings
55%
Success rate
14.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics | Maintained: Buy | $65 → $75 | $42.62 | +75.97% | 11 | Sep 16, 2026 | |
| ABSI Absci | Rated: Buy | $13 → $16 | $7.94 | +101.51% | 6 | Sep 8, 2026 | |
| KZIA Kazia Therapeutics | Rated: Buy | $34 → $40 | $10.36 | +286.10% | 4 | Sep 1, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $6.88 | - | 9 | Aug 10, 2026 | |
| VTVT vTv Therapeutics | Reiterated: Buy | $57 | $30.46 | +87.13% | 8 | Aug 6, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $24 | $11.65 | +106.01% | 6 | Aug 5, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $810 | $312.90 | +158.87% | 15 | Jun 29, 2026 | |
| BME: PHM Pharma Mar, S.A. | Initiated Coverage: Buy | €121.00 | €76.15 | +58.90% | 1 | Apr 23, 2026 | |
| ARQT Arcutis Biotherapeutics | Reiterated: Buy | $31 | $23.51 | +31.86% | 6 | Jan 15, 2026 | |
| LQDA Liquidia | Reiterated: Buy | $27 → $31 | $65.72 | n/a | 6 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $16.07 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.66 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.36 | n/a | 1 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $14 | $0.98 | n/a | 3 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.0008 | n/a | 1 | May 31, 2023 |
Rapport Therapeutics
Sep 16, 2026
Maintained: Buy
Price Target: $65 → $75
Current: $42.62
Upside: +75.97%
Absci
Sep 8, 2026
Rated: Buy
Price Target: $13 → $16
Current: $7.94
Upside: +101.51%
Kazia Therapeutics
Sep 1, 2026
Rated: Buy
Price Target: $34 → $40
Current: $10.36
Upside: +286.10%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $6.88
Upside: -
vTv Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $57
Current: $30.46
Upside: +87.13%
Zevra Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $24
Current: $11.65
Upside: +106.01%
Praxis Precision Medicines
Jun 29, 2026
Reiterated: Buy
Price Target: $810
Current: $312.90
Upside: +158.87%
Pharma Mar, S.A.
Apr 23, 2026
Initiated Coverage: Buy
Price Target: €121.00
Current: €76.15
Upside: +58.90%
Arcutis Biotherapeutics
Jan 15, 2026
Reiterated: Buy
Price Target: $31
Current: $23.51
Upside: +31.86%
Liquidia
May 28, 2025
Reiterated: Buy
Price Target: $27 → $31
Current: $65.72
Upside: n/a
Mar 25, 2025
Initiated Coverage: Buy
Price Target: $23
Current: $16.07
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $15
Current: $3.66
Upside: n/a
Apr 11, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $1.36
Upside: n/a
Mar 7, 2024
Reiterated: Buy
Price Target: $15 → $14
Current: $0.98
Upside: n/a
May 31, 2023
Upgraded: Buy
Price Target: $7
Current: $0.0008
Upside: n/a